Acute Lymphoblastic Leukemia, Pediatric Terminated Phase 1 / 2 Trials for Dexamethasone (DB01234)

Also known as: Pediatric Acute Lymphoblastic Leukemia / Acute Lymphoblastic Leukemia in Pediatric / Pediatric Patients With Acute Lymphoblastic Leukemia / Leukemia, Lymphoblastic, Acute, Pediatric

IndicationStatusPhase
DBCOND0081765 (Acute Lymphoblastic Leukemia, Pediatric)Terminated1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03705507International Trial of Selumetinib in Combination With Dexamethasone for the Treatment of Acute Lymphoblastic LeukaemiaTreatment